Results 191 to 200 of about 16,891 (263)

Single‐cell DNA methylation profiling: Technologies, computation, and applications in precision oncology

Molecular Oncology, EarlyView.
Single‐cell DNA methylation (scDNAme) profiling maps epimutational clonal evolution, revealing mechanisms of malignancy and therapeutic resistance across diverse cancer types. By providing a high‐resolution landscape of intratumoral heterogeneity, these technologies empower precise patient stratification, guide the development of enhanced ...
Ik Soo Kim
wiley   +1 more source

Assessment of Anthropogenic Pollen Signals in Anatolian Lake Records During the Beyşehir Occupation Phase. [PDF]

Plants (Basel)
Caner H, Güngör G.
europepmc   +1 more source

Targeting transcription factors associated with hemoglobinopathies: Lessons from successful interventions and implications for cancer

Molecular Oncology, EarlyView.
This review summarizes the transcription factors, repressive chromatin‐modifying complexes, and epigenetic mechanisms that control fetal hemoglobin repression. Notably, many regulators of γ‐globin silencing also function in transcriptional and epigenetic networks that drive cancer, highlighting opportunities to translate advances in hemoglobinopathy ...
Meigen Yu, Puspa Das, Xing Zhang, Xiaodong Cheng   +3 more
wiley   +1 more source

Archeological data with AI- and physics-based modeling explain typhoon-induced disasters in inland China around 3000 yr B.P. [PDF]

Sci Adv
Ding K, Li S, Ding A, Lu H, Zhang J, Xi D, Huang X, Lou S, Tang X, Qiu X, He L, Ma Y, Lin H, Zhang S, Zhou D, Zhou X, Tan ZM, Fu C, Ge Q.   +18 more
europepmc   +1 more source

Interferon beta drives therapy resistance in a patient‐derived model of high‐grade serous ovarian cancer

Molecular Oncology, EarlyView.
Interferon type 1 (IFN‐1) production and signaling is associated with the acquisition of therapy resistance, following chronic DNA damage, via Interferon‐related DNA damage resistance signature (IRDS) gene expression. An alternative, DNA damage‐independent role of sustained IFN‐1 mediated resistance was identified and characterized by the emergence of ...
Ashlyn Conant, Tise Suzuki, Kiera McGivney, V. S. S. Abhinav Ayyadevara, Sharon Asariah, Jay Deng, Ethan Nyein, Jacqueline Coats, Gary Yu, Yevgeniya J. Ioffe, Christian Hurtz, Juli J. Unternaehrer   +11 more
wiley   +1 more source

Tracing the Holocene hybrid origin of cultivated walnut in southwestern China. [PDF]

For Res (Fayettev)
Liu J, Qi HL, Fan PZ, Liu CM, Wu ZY, Luo YH, Milne RI, Khan R, Gao LM, Wang YH, Wambulwa MC, Shahi Shavvon R, Li DZ.   +12 more
europepmc   +1 more source

CEACAM1 participation in breast cancer progression

Molecular Oncology, EarlyView.
In invasive breast cancer (BC), CEACAM1 shifts from an apical to a uniform membranous/cytoplasmic pattern, or is lost, as tumors dedifferentiate, inversely tracking the Ki‐67 proliferative index. In MCF‐7 cells, only CEACAM1‐4L suppresses proliferation, repressing cell cycle and growth factor genes.
Mykola Lyndin, Irina Kube‐Golovin, Anatolii Romaniuk, Gunther Wennemuth   +3 more
wiley   +1 more source

10,000 years of centennially-resolved climate and sea-level change archived in Svalbard beach-ridge system. [PDF]

Sci Rep
Strzelecki MC, Lindhorst S, Hein CJ, van der Bilt WGM, Kivimaki KE, Kavan J.   +5 more
europepmc   +1 more source

PANoptosis in the pathogenesis of myelodysplastic syndromes

Molecular Oncology, EarlyView.
PANoptosis, a combination of three types of programmed cell death, is mediated by a large protein complex called a PANoptosome. In healthy bone marrow hematopoietic cells, PANoptosis is restricted by inhibitory signaling. In MDS, bone marrow cells become sensitive to the PANoptotic stimuli due to the aberrant inactivation of inhibitory signaling or ...
Rohit Thalla, Jyoti Lamichhane, Cameron Lewis, Peter Breslin, Jiwang Zhang   +4 more
wiley   +1 more source

Ground squirrel coprolites preserve complex archives of ancient environmental DNA over 700,000 years. [PDF]

Nat Commun
Murchie TJ, Cocker SL, Baleka S, Vogel NA, Natola L, Karpinski E, Tirlea D, Barrera MA, Grant DM, Morien E, Long GS, Rutledge LY, Zazula GD, Jensen BJ, Froese DG, Poinar HN.   +15 more
europepmc   +1 more source